Leahy Emer 4

What Happened
Director Emer Leahy received a grant (reported as an award/derivative) for 152,783 shares of Pasithea Therapeutics common stock on 2026-05-01. The transaction is reported at $0.00 because it is an option/award (not a cash purchase or sale) — no cash changed hands at grant and no shares were sold.

Key Details

• Transaction date: 2026-05-01; Form 4 filed: 2026-05-05 (timely filing).
• Transaction type/code: A (Award/Grant) — derivative security reported at $0.00.
• Amount: 152,783 shares underlying an option/award.
• Shares owned after transaction: not specified in this Form 4.
• Footnote: The award was made under the Issuer’s 2023 Stock Incentive Plan. The underlying shares vest in full on the one-year anniversary of the grant provided the reporting person remains a director; they will fully vest sooner on a Change in Control.

Context
This is a standard equity award to an insider (director) rather than an open-market purchase or sale. Because the grant vests after one year (or on a change in control), these are not immediately tradable shares and do not represent an immediate transfer of cash value or a sale by the insider.